Lamivudine treatment for acute hepatitis B after liver transplantation
- 1 December 1998
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 29 (6) , 985-989
- https://doi.org/10.1016/s0168-8278(98)80127-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study.Gastroenterology, 1997
- ALTERATION OF THE DISMAL NATURAL HISTORY OF FIBROSING CHOLESTATIC HEPATITIS SECONDARY TO HEPATITIS B VIRUS WITH THE USE OF LAMIVUDINETransplantation, 1997
- BENEFICIAL EFFECT OF LAMIVUDINE IN RECURRENT HEPATITIS B AFTER LIVER TRANSPLANTATIONTransplantation, 1997
- Liver transplantation in HBsAg-positive HBV-DNA-negative cirrhotics: Immunoprophylaxis and long-term outcomeLiver Transplantation and Surgery, 1996
- EFFICACY OF LAMIVUDINE IN CHRONIC HEPATITIS B PATIENTS WITH ACTIVE VIRAL REPLICATION AND DECOMPENSATED CIRRHOSIS UNDERGOING LIVER TRANSPLANTATION1Transplantation, 1996
- Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantationHepatology, 1995
- Liver Transplantation in European Patients with the Hepatitis B Surface AntigenNew England Journal of Medicine, 1993
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis BNew England Journal of Medicine, 1990
- Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBeGastroenterology, 1986